LUNDBECK ILAC TICARET LIMITED SIRKETI.

LUNDBECK ILAC TICARET LIMITED SIRKETI

Company Profile:

LUNDBECK ILAC TICARET LIMITED SIRKETI is the Turkish subsidiary of H. Lundbeck A/S, a global pharmaceutical company headquartered in Denmark. Lundbeck is dedicated to improving the lives of people living with brain diseases. The company develops, manufactures, and markets pharmaceutical products primarily focused on psychiatric and neurological disorders, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, and migraine. The Turkish entity is responsible for the marketing, sales, and distribution of Lundbeck's pharmaceutical products within the Turkish market, ensuring access to their specialized treatments for patients in Turkey. It operates as part of Lundbeck's global commercial network.

Company Type:

Trader. This entity primarily functions as the commercial and distribution arm for Lundbeck's pharmaceutical products in Turkey. While its parent company, H. Lundbeck A/S, is a manufacturer, LUNDBECK ILAC TICARET LIMITED SIRKETI itself is involved in the trade, import, and distribution of finished pharmaceutical goods.

Lundbeck Ilac Ticaret Limited Sirketi in Turkey markets and sells the following products:

* **Antidepressants:**

* Cipralex (Escitalopram)

* Lexapro (Escitalopram) - *Likely the same as Cipralex*

* **Antipsychotics:**

* Xanef (Lurasidone)

* **Other:**

* Ebixa (Memantine)

* Northera (Droxidopa)